.-In the present study, we tested the hypothesis that ANG II causes a greater vasoconstriction in obese Zucker rats, a model of type 2 diabetes, with mild hypertension. Measurement of isometric tension in isolated aortic rings with intact endothelium revealed a modest but not significantly greater ANG II-induced contraction in obese than lean rats. Removal of endothelium or inhibition of nitric oxide (NO) synthase by N G -nitro-Larginine methyl ester (L-NAME) enhanced 1) ANG II-induced contraction in both lean and obese rats, being significantly greater in obese rats (E max g/g tissue, denuded: lean 572 Ϯ 40 vs. obese 664 Ϯ 16; L-NAME: lean 535 Ϯ 14 vs. obese 818 Ϯ 23) and 2) ANG II sensitivity in obese compared with lean rats, as revealed by the pD2 values. Endothelin-1 and KCl elicited similar contractions in the aortic rings of lean and obese rats. ACh, a NO-dependent relaxing hormone, produced greater relaxation in the aortic rings of obese than lean rats, whereas sodium nitroprusside, an NO donor, elicited similar relaxations in both rat strains. The expression of the ANG type 1 (AT1) receptor protein and mRNA in the endothelium-intact aorta was significantly greater in obese than lean rats, whereas the endotheliumdenuded rings expressed modest but not significantly greater levels of AT1 receptors in obese than lean rats. The endothelial NO synthase protein and mRNA expression levels were higher in the aorta of obese than lean animals. We conclude that, although ANG II produces greater vasoconstriction in obese rat aortic rings, enhanced endothelial AT1 receptor-mediated NO production appears to counteract the increased ANG II-induced vasoconstriction, suggesting that arterial AT1 receptor may not be a contributing factor to hypertension in this model of obesity. angiotensin II; endothelium; thoracic aorta; N G -nitro-L-arginine methyl ester; angiotensin II type 1 receptor messenger ribonucleic acid ANG II, THE primary active product of the renin-angiotensin system (RAS), plays an important role in the regulation of cardiovascular hemodynamics via two distinct subtypes of receptors, ANG type 1 (AT 1 ) and type 2 (AT 2 ) receptors. The AT 1 and the AT 2 receptors belong to the superfamily of G protein-coupled receptors (12). ANG II, via the activation of AT 1 receptors, causes vasoconstriction, aldosterone secretion, sympathetic activation, and renal sodium reabsorption and thereby regulates the blood pressure and sodium and water homeostasis (9,22,26). There is evidence that suggests the role of AT 2 receptors to elicit vasodilatation, sodium excretion, and blood pressure reduction and thereby counteract the effects of AT 1 receptors (25,35).